Rx 'Reformulation' In Herbal Sleep Aid Gives FDA A Nightmare
This article was originally published in The Pink Sheet
Executive Summary
FDA inspects Belmora's website and product labeling in March and issues a warning letter that firm’s Elavil OTC Sleep Aid is an unapproved new drug with inadequate directions for its intended use.
You may also be interested in...
Spiked Supplement Holiday Deliveries Stopped By Import Examinations
FDA alerts consumers and health care providers to 13 products found in examinations of international mail shipments to contain sildenafil and one with the banned drug sibutramine.
Drug Product Recalls in 2013 Categorized by Problem Area
This comprehensive table provides key facts at a glance for every one of the 1,276 drug recalls FDA reported last year, grouped into seven main problem areas. For each recall, it says what product was recalled and how much of it was recalled, what company manufactured it and recalled it, how seriously FDA rated the health threat the recalled product posed, and what reason the company gave for recalling the product.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.